Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

ALLO

Live52w high -57.4%

Loading latest news…

Log in Get Started

☁️ News word cloud

Top words across the last 50 articles for this ticker.

therapeuticsallogenenasdaq2024developmentcancerannouncedclinicalallogeneiccelldiseasetodayallocarmarketproductsmilliontrialpioneeringbiotechnologytreatment

Loading latest news…

52w high -57.4%

☁️ News word cloud

Top words across the last 50 articles for this ticker.

therapeuticsallogenenasdaq2024developmentcancerannouncedclinicalallogeneiccelldiseasetodayallocarmarketproductsmilliontrialpioneeringbiotechnologytreatment